Fitch Ratings upgraded its credit grade on both Bausch + Lomb Corp. and its parent company Bausch Health Cos., but said the ...

LAVAL, QC / ACCESS Newswire / April 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch ...

Bausch + Lomb has gotten torched over the last six months - since October 2024, its stock price has dropped 41.5% to $12.06 ...

Bausch Health Companies (BHC) and its gastroenterology business, Salix Pharmaceuticals, announced the U.S. District Court for the District of ...

The refinancing initiative has significantly reduced Bausch Health’s near-term refinancing risk, a factor that previously contributed to its ’CCC’ rating. The company now has limited near-term ...

Bausch + Lomb, a leading global eye health company, announced a voluntary recall of its Envista Aspire, Envista Envy and ...

Fitch Ratings has upgraded the Issuer Default Rating (IDR) of Bausch + Lomb Corporation (BLCO) to ’B’ from ’B-’ on April 17, 2025. The rating on its senior secured debt was also raised to ’BB’ with a ...

LAVAL, QC / ACCESS Newswire / April 17, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health"), and its gastroenterology business Salix Pharmaceuticals, Inc., today ...

Investing.com -- Bausch Health Companies Inc (NYSE: BHC) stock closed up 13.3% following a favorable court decision. The U.S. District Court for the District of Columbia ruled in favor of the company ...

Canada's commodity-linked main stock index extended its recent winning streak on Thursday as oil prices climbed and recent ...

Michael Croft recently published a novel, The Eleanor. He stopped by Morning Break to share the inspiration behind the book which includes experiences from his own life. His family owned the Parkway ...